8 May 2025 Date | | - Cons. EPS | - EPS |
4 Nov 2024 Date | | - Cons. EPS | - EPS |
1 Nov 2024 Date | | - Cons. EPS | - EPS |
31 Oct 2024 Date | | - Cons. EPS | - EPS |
10 Aug 2024 Date | | - Cons. EPS | - EPS |
8 May 2025 Date | | - Cons. EPS | - EPS |
4 Nov 2024 Date | | - Cons. EPS | - EPS |
1 Nov 2024 Date | | - Cons. EPS | - EPS |
31 Oct 2024 Date | | - Cons. EPS | - EPS |
10 Aug 2024 Date | | - Cons. EPS | - EPS |
Consulting Services Industry | Industrials Sector | Mr. Michael D. Farkas CEO | OTC PINK Exchange | US05762T1034 ISIN |
United States Country | 4 Employees | - Last Dividend | - Last Split | - IPO Date |
Balance Labs, Inc. operates as a dynamic consulting firm, extending its expertise to startup and development-stage businesses both in the United States and internationally. Established in 2014 and headquartered in Miami Beach, Florida, the company distinguishes itself by offering a broad range of services tailored to improve and refine business models, sales, marketing strategies, and internal operations. As a subsidiary of Balance Holdings, LLC, Balance Labs, Inc. leverages its network and expertise to facilitate business growth and efficiency, making it a pivotal partner for businesses across diverse sectors seeking to scale their operations and impact.